FNT
LLY icon

First National Trust’s Eli Lilly LLY Stock Holding History

First National Trust’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.6M Buy
34,377
+1,859
+6% +$1.88M 1.08% 20
2025
Q4 		$34.9M Sell
32,518
-217
-0.7% -$207K 1.17% 16
2025
Q3 		$25M Buy
32,735
+147
+0.5% +$109K 0.86% 26
2025
Q2 		$25.4M Sell
32,588
-823
-2% -$640K 0.95% 22
2025
Q1 		$27.6M Sell
33,411
-624
-2% -$519K 1.11% 17
2024
Q4 		$26.3M Buy
34,035
+3,096
+10% +$2.56M 0.99% 20
2024
Q3 		$27.4M Sell
30,939
-205
-0.7% -$184K 1.06% 19
2024
Q2 		$28.2M Buy
31,144
+1,536
+5% +$1.23M 1.16% 17
2024
Q1 		$23M Buy
29,608
+4,527
+18% +$3.22M 0.94% 25
2023
Q4 		$14.6M Sell
25,081
-330
-1% -$193K 0.64% 44
2023
Q3 		$13.6M Sell
25,411
-224
-0.9% -$115K 0.65% 45
2023
Q2 		$12M Sell
25,635
-452
-2% -$190K 0.56% 50
2023
Q1 		$8.96M Sell
26,087
-371
-1% -$125K 0.48% 64
2022
Q4 		$9.68M Sell
26,458
-515
-2% -$183K 0.51% 59
2022
Q3 		$8.72M Sell
26,973
-383
-1% -$121K 0.51% 61
2022
Q2 		$8.87M Sell
27,356
-1,443
-5% -$433K 0.5% 61
2022
Q1 		$8.25M Sell
28,799
-709
-2% -$182K 0.43% 76
2021
Q4 		$8.15M Sell
29,508
-1,148
-4% -$291K 0.43% 78
2021
Q3 		$7.08M Sell
30,656
-311
-1% -$76.8K 0.42% 75
2021
Q2 		$7.11M Sell
30,967
-1,211
-4% -$243K 0.43% 73
2021
Q1 		$6.01M Sell
32,178
-1,281
-4% -$251K 0.39% 83
2020
Q4 		$5.65M Sell
33,459
-1,754
-5% -$262K 0.39% 81
2020
Q3 		$5.21M Sell
35,213
-683
-2% -$106K 0.41% 72
2020
Q2 		$5.89M Sell
35,896
-696
-2% -$107K 0.5% 61
2020
Q1 		$5.08M Sell
36,592
-1,764
-5% -$242K 0.51% 62
2019
Q4 		$5.04M Sell
38,356
-1,289
-3% -$149K 0.41% 74
2019
Q3 		$4.43M Sell
39,645
-2,977
-7% -$331K 0.4% 77
2019
Q2 		$4.72M Sell
42,622
-2,070
-5% -$244K 0.44% 69
2019
Q1 		$5.8M Sell
44,692
-3,188
-7% -$388K 0.58% 51
2018
Q4 		$5.54M Sell
47,880
-2,629
-5% -$294K 0.62% 52
2018
Q3 		$5.42M Sell
50,509
-1,616
-3% -$162K 0.55% 51
2018
Q2 		$4.45M Sell
52,125
-1,419
-3% -$117K 0.49% 61
2018
Q1 		$4.14M Sell
53,544
-7,623
-12% -$614K 0.47% 62
2017
Q4 		$5.17M Sell
61,167
-4,299
-7% -$366K 0.57% 51
2017
Q3 		$5.6M Sell
65,466
-6,369
-9% -$522K 0.65% 42
2017
Q2 		$5.91M Buy
71,835
+40
+0.1% +$3.26K 0.72% 36
2017
Q1 		$6.04M Sell
71,795
-14,016
-16% -$1.12M 0.78% 32
2016
Q4 		$6.31M Sell
85,811
-975
-1% -$72.6K 0.89% 29
2016
Q3 		$6.97M Buy
86,786
+952
+1% +$76.2K 1.05% 26
2016
Q2 		$6.76M Sell
85,834
-4,576
-5% -$345K 1.04% 25
2016
Q1 		$6.51M Sell
90,410
-787
-0.9% -$59.5K 1% 25
2015
Q4 		$7.68M Sell
91,197
-786
-0.9% -$65.2K 1.22% 19
2015
Q3 		$7.7M Sell
91,983
-1,925
-2% -$163K 1.32% 13
2015
Q2 		$7.84M Buy
93,908
+874
+0.9% +$66.6K 1.26% 17
2015
Q1 		$6.76M Buy
93,034
+3,586
+4% +$255K 1.15% 21
2014
Q4 		$6.17M Buy
89,448
+1,963
+2% +$133K 1.1% 23
2014
Q3 		$5.67M Buy
87,485
+1,419
+2% +$89.8K 1.07% 23
2014
Q2 		$5.35M Buy
86,066
+787
+0.9% +$47K 1.03% 24
2014
Q1 		$5.02M Buy
85,279
+728
+0.9% +$40.6K 0.9% 31
2013
Q4 		$4.31M Sell
84,551
-2,511
-3% -$126K 0.79% 37
2013
Q3 		$4.38M Buy
87,062
+103
+0.1% +$5.39K 0.86% 32
2013
Q2 		$4.27M Buy
+86,959
New +$4.73M 0.88% 30

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

First National Trust's LLY Position: Q1 2026 in Review

First National Trust increased its Eli Lilly (LLY) stake by 5.7% in Q1 2026, buying an estimated $1.88M and bringing the position to 34,377 shares worth $31.6M. The position accounts for 1.08% of the portfolio, ranked #20.

First National Trust first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $34.9M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • First National Trust held 34,377 shares of Eli Lilly worth $31.6M as of Q1 2026.
  • First National Trust bought 1,859 Eli Lilly shares in Q1 2026, an estimated $1.88M.
  • Eli Lilly made up 1.08% of First National Trust's portfolio in Q1 2026, its #20 holding.
  • First National Trust first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • First National Trust's Eli Lilly position peaked at $34.9M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on First National Trust's 13F filing for Q1 2026, filed 7 May 2026.